ArticleAIDS research and therapy2025
High dyslipidemia in people living with HIV in ghana: a cross-sectional analysis of prevalence and associated factors.
Article in AIDS research and therapy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCardiovascular disease (CVD) is a leading cause of mortality among people living with HIV (PLHIV) in sub-Saharan Africa. Dyslipidemia, a major modifiable CVD risk factor, is poorly characterized in Ghanaian PLHIV, particularly across age groups. This study determined the prevalence and factors associated with dyslipidemia among PLHIV in Ghana's Eastern Region.
methodsA facility-based cross-sectional study was conducted between February and June 2020 at two hospitals (Atua Government Hospital and St. Martins de Porres Hospital). We enrolled 440 PLHIV aged ≥ 18 years on antiretroviral therapy (ART) for ≥ 6 months, excluding pregnant/lactating individuals and those on special diets. Participants were categorized into three age groups: 18-34, 35-54, and ≥ 55 years. Dyslipidemia was defined per the National Cholesterol Education Program Adult Treatment Panel III (NCEP ATP III) criteria (elevated triglycerides ≥ 150 mg/dL, LDL-C ≥ 130 mg/dL, or HDL-C < 40 mg/dL). Data on sociodemographic, lifestyle, ART history, and body composition were collected using structured questionnaires and physical measurements. Bivariate analyses and binary logistic regression identified determinants (p < 0.05).
resultsThe overall prevalence of dyslipidemia was 64.1% (95% CI: 59.5-68.5%). The prevalence was higher among females (64.4%) compared with males (58.2%). Regression analysis identified significant independent predictors: alcohol use (aOR = 2.05, 95% CI:1.20-3.52), physical inactivity (aOR = 1.88, 95% CI:1.12-3.15), higher BMI (aOR = 1.24 per unit increase, 95% CI:1.02-1.50), and muscle mass (aOR = 0.85 per unit increase, 95% CI:0.75-0.97). Unexpectedly, participants who reported never smoking had lower odds of dyslipidemia (aOR = 0.16, 95% CI: 0.06-0.41). No significant associations were found with ART regimen/duration, education, or age.
conclusionDyslipidemia is highly prevalent among Ghanaian PLHIV and is strongly associated with modifiable lifestyle and body composition factors. Integrated interventions targeting alcohol reduction, physical activity promotion, and weight management are urgently needed within routine HIV care. The unexpected association with smoking warrants further investigation.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.